Resource
HERS - Summary for General Practitioners about the breast cancer drug Trastuzumab (Herceptin®)
This is a summary that may be helpful for general practitioners in answering patient’s questions about trastuzumab. It is based on clinical practice guideline 
HERG - Recommendations for Trastuzumab (Herceptin®) for treatment of HER2-positive breast cancer (291.85 kB).
| Filename | hers-trastuzumab-herceptin-for-general-practitioners.pdf |
| Filesize | 673 kB |
| Filetype | pdf (Mime Type: application/pdf) |
| Created On: | 01/07/2007 00:00 |
| Last updated on | 22/05/2009 22:36 |